Home / CCL4/MIP-1 beta / Mouse CCL4/MIP-1 beta Antibody

Mouse CCL4/MIP-1 beta Antibody

Catalog #: MAB451
11 Citations Datasheet / COA / SDS
Catalog # Availability Size / Price Qty
MAB451-SP
MAB451-500
MAB451-100
Chemotaxis Induced by CCL4/MIP‑1 beta and Neutralization by Mouse CCL4/MIP‑1 beta Antibody.
1 Image
Product Details
Citations (11)
FAQs
Supplemental Products
Reviews
Summary Data Examples Preparation and Storage Reconstitution Calculator Background Product Datasheets Related Research Areas

Mouse CCL4/MIP-1 beta Antibody Summary

Species Reactivity
Mouse
Specificity
Detects mouse CCL4/MIP-1 beta in ELISAs. Does not cross-react with recombinant human (rh) CCL1, 2, 4/MIP-1 alpha, 4/MIP-1 beta, 5, 7, 8, 11, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, rmCCL1, 2, 4/MIP-1 alpha, 4/MIP-1 beta, 5, 6, 7, 9/10, 11, 12, 17, 19, 20, 21, 22, 24, 25, or rrCCL20.
Source
Monoclonal Rat IgG2A Clone # 46907
Purification
Protein A or G purified from hybridoma culture supernatant
Immunogen
E. coli-derived recombinant mouse CCL4/MIP-1 beta
Ala24-Asn92
Accession # Q5QNV9
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Endotoxin Level
<0.10 EU per 1 μg of the antibody by the LAL method.
Label
Unconjugated

Applications

Recommended Concentration
Sample
Neutralization
Measured by its ability to neutralize CCL4/MIP‑1 beta -induced chemotaxis in the BaF3 mouse pro‑B cell line transfected with human CCR5. The Neutralization Dose (ND50) is typically 1-3 µg/mL in the presence of 25 ng/mL Recombinant Mouse CCL4/MIP‑1 beta.

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Scientific Data

Neutralization Chemotaxis Induced by CCL4/MIP‑1 beta and Neutralization by Mouse CCL4/MIP‑1 beta Antibody. View Larger

Chemotaxis Induced by CCL4/MIP‑1 beta and Neutralization by Mouse CCL4/MIP‑1 beta Antibody. Recombinant Mouse CCL4/MIP-1 beta (Catalog # 451-MB) chemoattracts the BaF3 mouse pro-B cell line transfected with human CCR5 in a dose-dependent manner (orange line). The amount of cells that migrated through to the lower chemotaxis chamber was measured by Resazurin (Catalog # AR002). Chemotaxis elicited by Recombinant Mouse CCL4/MIP-1 beta (25 ng/mL) is neutralized (green line) by increasing concentrations of Rat Anti-Mouse CCL4/MIP-1 beta Monoclonal Antibody (Catalog # MAB451). The ND50 is typically 1-3 µg/mL.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Preparation and Storage

Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS.
Loading...
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: CCL4/MIP-1 beta

CCL4, also known as macrophage inflammatory protein 1 beta (MIP-1 beta ), is a 12 kDa beta chemokine that is secreted at sites of inflammation by activated leukocytes, lymphocytes, vascular endothelial cells, and pulmonary smooth muscle cells (1, 2). CCL4 attracts a variety of immune cells to sites of microbial infection as well as to other pathologic inflammation such as allergic asthma and ischemic myocardium (3-8). A CCL4 deficiency in mice promotes the development of autoantibodies, possibly as a result of compromised regulatory T cell recruitment (6). CCL4 is secreted from activated monocytes as a heterodimer with CCL3/MIP-1 alpha (9). The first two N-terminal amino acids can be cleaved from human CCL4 by CD26/DPPIV (10, 11). Both the full length and truncated forms exert biological activity through CCR5, and the truncated form additionally interacts with CCR1 and CCR2 (10). In humans, the ability of CCL4 to bind CCR5 inhibits the cellular entry of M-tropic HIV-1 which utilizes CCR5 as a co-receptor (2). Both forms of CCL4 block HIV-1 infection of T cells by inducing the downregulation of CCR5 (10). Mature mouse CCL4 shares 77% and 86% amino acid sequence identity with human and rat CCL4, respectively.

References
  1. Rot, A. and U.H. von Andrian (2004) Annu. Rev. Immunol. 22:891.
  2. Menten, P. et al. (2002) Cytokine Growth Factor Rev. 13:455.
  3. Sun, X. et al. (2006) Infec. Immun. 74:5943.
  4. Bisset, L.R. and Schmid-Grendelmeier, P. (2005) Curr. Opin. Pulm. Med. 11:35.
  5. Frangogiannis, N.G. (2004) Inflamm. Res. 53:585.
  6. Bystry, R.S. et al. (2001) Nat. Immunol. 2:1126.
  7. Oliveira, S.H.P. et al. (2002) J. Leukoc. Biol. 71:1019.
  8. Schall, T.J. et al. (1993) J. Exp. Med. 177:1821.
  9. Guan, E. et al. (2001) J. Biol. Chem. 276:12404.
  10. Guan, E. et al. (2002) J. Biol. Chem. 277:32348.
  11. Guan, E. et al. (2004) J. Cell. Biochem. 92:53.
Entrez Gene IDs
6351 (Human); 20303 (Mouse); 116637 (Rat); 448786 (Canine); 102117861 (Cynomolgus Monkey)
Alternate Names
ACT2; ACT-2; AT744.1; C-C motif chemokine 4; CCL4; chemokine (C-C motif) ligand 4; Exodus-3; G-26 T-lymphocyte-secreted protein; G-26; HC21; LAG1; LAG-1; Lymphocyte activation gene 1 protein; Macrophage inflammatory protein 1-beta; MIP1 beta; MIP-1 beta; MIP1B; MIP1B1; MIP-1-beta; MIP-1-beta(1-69); PAT 744; Protein H400; SCYA2; SCYA4; secreted protein G-26; SIS-gamma; small inducible cytokine A4 (homologous to mouse Mip-1b); Small-inducible cytokine A4; T-cell activation protein 2

Product Datasheets

You must select a language.

x
Product Datasheet
COA
SDS

Citations for Mouse CCL4/MIP-1 beta Antibody

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

11 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. A Novel Resolution of Diabetes: C-C Chemokine Motif Ligand 4 Is a Common Target in Different Types of Diabetes by Protecting Pancreatic Islet Cell and Modulating Inflammation
    Authors: Ting-Ting Chang, Liang-Yu Lin, Jaw-Wen Chen
    Frontiers in Immunology
  2. Intratumoral gamma δ T‐Cell Infiltrates, Chemokine (C‐C Motif) Ligand 4/Chemokine (C‐C Motif) Ligand 5 Protein Expression and Survival in Patients With Hepatocellular Carcinoma
    Authors: Na Zhao, Hien Dang, Lichun Ma, Sean P. Martin, Marshonna Forgues, Kris Ylaya et al.
    Hepatology
  3. CCL4 Inhibition in Atherosclerosis: Effects on Plaque Stability, Endothelial Cell Adhesiveness, and Macrophages Activation
    Authors: Chang TT, Yang HY, Chen C, Chen JW.
    International Journal of Molecular Sciences
  4. Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells.
    Authors: Ortiz M, Kumar V, Martner A, Mony S, Donthireddy L, Condamine T, Seykora J, Knight S, Malietzis G, Lee G, Moorghen M, Lenox B, Luetteke N, Celis E, Gabrilovich D
    J Exp Med, 2015-02-09;212(3):351-67.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  5. Cognate antigen stimulation generates potent CD8(+) inflammatory effector T cells
    Authors: Hsueh-Cheng Sung, Sara Lemos, Patricia Ribeiro-Santos, Kateryna Kozyrytska, Florence Vasseur, Agnès Legrand et al.
    Frontiers in Immunology
  6. An aberrant thymus in CCR5-/- mice is coupled with an enhanced adaptive immune response in fungal infection.
    Authors: Kroetz DN, Deepe GS
    J. Immunol., 2011-04-08;186(10):5949-55.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  7. Neutralization of interleukin-16 protects nonobese diabetic mice from autoimmune type 1 diabetes by a CCL4-dependent mechanism.
    Authors: Meagher C, Beilke J, Arreaza G
    Diabetes, 2010-08-06;59(11):2862-71.
    Species: Mouse
    Sample Types: In Vivo
    Applications: Neutralization
  8. The direct action of 1alpha,25(OH)2-vitamin D3 on purified mouse Langerhans cells.
    Authors: Fujita H, Asahina A, Komine M, Tamaki K
    Cell. Immunol., 2007-05-15;245(2):70-9.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Neutralization
  9. Regulatory effects of eotaxin on acute lung inflammatory injury.
    Authors: Guo RF, Lentsch AB, Warner RL, Huber-Lang M, Sarma JV, Hlaing T, Shi MM, Lukacs NW, Ward PA
    J. Immunol., 2001-04-15;166(8):5208-18.
    Species: Mouse
    Sample Types: Cell Culture Supernates
    Applications: ELISA Development
  10. Direct CCL4 Inhibition Modulates Gut Microbiota, Reduces Circulating Trimethylamine N-Oxide, and Improves Glucose and Lipid Metabolism in High-Fat-Diet-Induced Diabetes Mellitus
    Authors: Ting-Ting Chang, Jaw-Wen Chen
    Journal of Inflammation Research
  11. Cytotoxic T cells swarm by homotypic chemokine signalling
    Authors: Jorge Luis Galeano Niño, Sophie V Pageon, Szun S Tay, Feyza Colakoglu, Daryan Kempe, Jack Hywood et al.
    eLife

FAQs

No product specific FAQs exist for this product, however you may

View all Antibody FAQs
Loading...

Reviews for Mouse CCL4/MIP-1 beta Antibody

There are currently no reviews for this product. Be the first to review Mouse CCL4/MIP-1 beta Antibody and earn rewards!

Have you used Mouse CCL4/MIP-1 beta Antibody?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review